Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Care Interventions in PEG-fed Palliative Care Patients
NCT07792473Not yet recruiting
- Sponsor
- Yalova University
- Start
- Sep 2026
- Primary completion
- Feb 2027
01
Overview
Randomised, open-label trial of Ankaferd Hemostat and benzydamine in oral mucositis (OM) (3 arms), sponsored by Yalova University. Primary endpoint: Oral Mucositis Assessment Scale Score at Day 15. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Ankaferd Hemostatbenzydamine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07792473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792473.